Deflazacort Oral Suspension
Product Images NDC 57664-993

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Deflazacort Oral Suspension (NDC 57664-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

Packaging label for Deflazacort Oral Suspension 22.75 mg/mL by Sun Pharmaceutical Industries, Inc. The carton is for a prescription oral suspension, 13 mL bottle with included oral dispensers and a bottle adapter. The label includes storage instructions, dosage form, and manufacturer details with barcode and NDC 57664-993-01.*

FDA Label Image

Container Label (Container Label)

Label for Deflazacort Oral Suspension 22.75 mg/mL, an oral human prescription drug by Sun Pharmaceutical Industries, Inc. The label shows the product name, strength, dosage form, volume of 13 mL, manufacturer and distributor information, as well as usage and storage instructions. A barcode and non-vernish area mark are also visible.*

FDA Label Image

Tris Chemdraw Structure (Deflazacort Oral Suspension 1)

Chemical structure of Deflazacort, the active ingredient in Deflazacort Oral Suspension. The diagram shows the molecular configuration, including functional groups and stereochemistry relevant to Deflazacort.*

FDA Label Image

Figure I (Deflazacort Oral Suspension 10)

An instructional illustration showing a hand holding a measuring syringe above a small cup filled with liquid alongside a spoon, with a downward arrow indicating liquid is to be drawn into the syringe from the cup.*

FDA Label Image

Figurej (Deflazacort Oral Suspension 11)

An instructional illustration showing a hand stirring liquid inside a cup with a spoon. The image indicates a stirring motion with an arrow around the rim of the cup, suggesting proper mixing technique.*

FDA Label Image

Figurek (Deflazacort Oral Suspension 12)

An instructional diagram showing a hand removing or loosening a protective seal or cap from the neck of a bottle. The arrow indicates the direction to lift or pull the seal upward from the bottle opening.*

FDA Label Image

Figure L (Deflazacort Oral Suspension 13)

An instructional diagram showing a hand holding a syringe labeled with volume measurements from 0.1 mL to 1 mL. The syringe has two labeled parts: 'Plunger' at the top and 'Barrel' along the main body. An upward arrow indicates the direction to pull the plunger out of the barrel, demonstrating how to use the syringe to measure oral suspension.*

FDA Label Image

Figure A (Deflazacort Oral Suspension 2)

Illustration showing components included with Deflazacort Oral Suspension, featuring the oral suspension bottle, a household cup with spoon, a bottle adapter, an oral dispenser, and the suspension carton packaging.*

FDA Label Image

Figureb (Deflazacort Oral Suspension 3)

An instructional line drawing showing a hand holding a bottle and shaking it vertically with motion lines and an arrow indicating to "Shake Well." This illustration is intended to demonstrate proper handling of the bottle before use.*

FDA Label Image

Figurec (Deflazacort Oral Suspension 4)

An instructional illustration showing a hand pressing down on the cap of a bottle. Two arrows indicate the pressing motion, demonstrating how to open or close the bottle cap, likely related to the Deflazacort Oral Suspension packaging.*

FDA Label Image

Figured (Deflazacort Oral Suspension 5)

An instructional illustration showing hands pressing down on a bottle adapter with both thumbs to remove or open it. The diagram highlights the ribbed end of the bottle adapter being pressed down for proper opening or closing.*

FDA Label Image

Figure E (Deflazacort Oral Suspension 6)

An instructional illustration of an oral syringe labeled with volume markings from 0.1 mL to 1 mL. The plunger and barrel components of the syringe are identified by arrows and labels.*

FDA Label Image

Figure F (Deflazacort Oral Suspension 7)

An instructional diagram shows a hand holding a syringe-like oral dosing dispenser labeled with volume markings from 0.1 mL to 1.0 mL. The dispenser is positioned above the open neck of a bottle, with a large downward arrow indicating insertion of the plunger into the bottle opening. The plunger is labeled at the top.*

FDA Label Image

Figure G (Deflazacort Oral Suspension 8)

An instructional diagram showing how to measure the dose of oral suspension using a syringe. The syringe is marked with volume measurements in milliliters from 0.1 mL to 1.0 mL. A magnified inset highlights the instruction to measure dose from the widest part of the plunger. The diagram depicts a bottle attached to the syringe and a hand holding the plunger.*

FDA Label Image

Figure H (Deflazacort Oral Suspension 9)

An instructional illustration showing a hand inserting a syringe into a bottle, with volume markings from 0.2 mL to 1 mL visible on the syringe. An arrow indicates pulling the syringe upward, and a curved arrow suggests twisting or removing the bottle cap. This depicts how to measure and withdraw oral suspension from a bottle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.